SCA practice case · Video consultation
“Insulin means I’ve failed, doesn’t it? And I’ll go blind like my mum — I don’t want needles”
Video consultation
Adult patient
Typical
Long-term conditions & cancerProfessional & ethical dilemmas
The candidate brief
This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.
Patient
Sanjay Mehta · 59 years · male
Setting
Video consultation — recommending insulin for poorly controlled type 2 diabetes.
Past history
- Type 2 diabetes
- HbA1c 86 mmol/mol on maximal oral therapy
Medication
- Oral glucose-lowering medicines (as on repeat record)
Allergies
None recorded
Recent notes
⚠ HbA1c 86 mmol/mol despite maximal oral therapy. Insulin recommended at last review. Occupation: taxi driver.
Reason for contact
Video appointment to discuss insulin. “Does this mean I’ve failed?”
Practise this case
The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.
What this case tests
Show the learning points (spoiler: read after you have practised)
Starting insulin in type 2 diabetes is as much about BELIEFS and SAFETY as pharmacology. Elicit and reframe the common feeling that insulin means personal FAILURE: type 2 diabetes is PROGRESSIVE — the pancreas makes less insulin over time — so needing insulin reflects the natural course, not a lack of effort, and is a positive, effective step. Explore and correct the frequent misattribution that "insulin caused my relative’s blindness/decline": complications such as retinopathy, nephropathy and neuropathy arise from poorly controlled diabetes (and, for older relatives, an earlier treatment era), whereas good glucose control — which insulin helps achieve — REDUCES that risk. Provide practical education (fine, near-painless pen needles; technique and site rotation; a basal-insulin start titrated to fasting glucose, or — per NICE NG28 — basal plus short- or rapid-acting insulin from the start when HbA1c is 75 mmol/mol or higher; review of a sulfonylurea; DSN/structured-education support). Counsel HYPOGLYCAEMIA thoroughly — recognition (sweating, tremor, hunger, palpitations, confusion), treatment with 15–20 g of fast-acting carbohydrate, rechecked after 10–15 minutes, then a longer-acting snack (JBDS-IP), always carrying carbs, risk factors (missed meals, alcohol, exercise) and when to seek help. Critically, cover the DVLA/DRIVING duty for insulin: the patient MUST inform the DVLA if insulin will last more than 3 months, check glucose no more than 2 hours before driving and every 2 hours while driving (5.0 mmol/L or below — eat before driving; below 4.0 — do not drive, and wait 45 minutes after recovery), carry fast-acting carbohydrate, and never drive with impaired hypo awareness (DVLA Assessing fitness to drive, November 2025 edition; INF294) — and a taxi driver, though licensed under Group 1, must also tell the council licensing authority, which generally applies the stricter Group 2 standard (no severe hypo in 12 months, twice-daily monitoring, CGM allowed since November 2025); advise clearly, document, and frame supportively because good management usually permits continued driving. The hidden agenda is layered fear (failure, a relative’s fate, hypos, losing licence/income); surface and address each empathically, equip the patient with hypo and driving knowledge, involve the DSN, and reach a SHARED decision — neither overriding fear with facts alone nor capitulating to ongoing poor control.
The guidance behind it
Similar SCA cases
gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.